Differences in the severity of small bowel mucosal injury based on the type of aspirin as evaluated by capsule endoscopy

Digestive and Liver Disease

Volumn 44, Issue 10, 2012, Pages 833-838

  Endo, Hiroki ^a   Sakai, Eiji ^a   Higurashi, Takuma ^a   Yamada, Eiji ^a   Ohkubo, Hidenori ^a   Iida, Hiroshi ^a   Koide, Tomoko ^a   Yoneda, Masato ^a   Abe, Yasunobu ^a   Inamori, Masahiko ^a   Hosono, Kunihiro ^a   Takahashi, Hirokazu ^a   Kubota, Kensuke ^a   Nakajima, Atsushi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Capsule endoscopy; Low dose aspirin; Small Bowel

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; ARTICLE; CAPSULE ENDOSCOPY; CONTROLLED STUDY; DISEASE SEVERITY; ENTERITIS; EROSION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; INTESTINE INJURY; INTESTINE MUCOSA; INTESTINE ULCER; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

AGED; ASPIRIN; CAPSULE ENDOSCOPY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84865764270     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2012.05.016     Document Type: Article

References (27)

1. Awtry E.H., Loscalzo J. Aspirin. Circulation 2000, 101:1206-1218.
2. Antithrombotic Trialists Collaboration Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. British Medical Journal 2002, 324:71-86.
3. Patrono C., García Rodríguez L.A., Landolfi R., et al. Low-dose aspirin for the prevention of atherothrombosis. New England Journal of Medicine 2005, 353:2373-2383.
4. Weil J., Colin-Jones D., Langman M., et al. Prophylactic aspirin and risk of peptic ulcer bleeding. British Medical Journal 1995, 310:827-830.
5. Patrono C. Aspirin as an antiplatelet drug. New England Journal of Medicine 1994, 330:1287-1294.
6. Graham D.Y., Opekun A.R., Willingham F.F., et al. Visible small-intestinal mucosal injury in chronic NSAID users. Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association 2005, 3:55-59.
7. Maiden L., Thjodleifsson B., Theodors A., et al. A quantitative analysis of NSAID-induced small bowel pathology by capsule endoscopy. Gastroenterology 2005, 128:1172-1178.
8. Maiden L., Thjodleifsson B., Seigal A., et al. Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study. Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association 2007, 5:1040-1045.
9. Goldstein J.L., Eisen G.M., Lewis B., et al. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association 2005, 3:133-141.
10. Goldstein J.L., Eisen G.M., Lewis B., et al. Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy. Alimentary Pharmacology and Therapeutics 2007, 25:1211-1222.
11. Endo H., Hosono K., Inamori M., et al. Incidence of small bowel injury induced by low-dose aspirin: a crossover study using capsule endoscopy in healthy volunteers. Digestion 2009, 79:44-51.
12. Endo H., Hosono K., Inamori M., et al. Characteristics of small bowel injury in symptomatic chronic low-dose aspirin users: the experience of two medical centers in capsule endoscopy. Journal of Gastroenterology 2009, 44:544-549.
13. Matsumoto T., Kudo T., Esaki M., et al. Prevalence of non-steroidal anti-inflammatory drug-induced enteropathy determined by double-balloon endoscopy: a Japanese multicenter study. Scandinavian Journal of Gastroenterology 2008, 43:490-496.
14. Graham D.Y., Smith J.L. Aspirin and the stomach. Annals of Internal Medicine 1986, 104:390-398.
15. Banoob D.W., McCloskey W.W., Webster W. Risk of gastric injury with enteric- versus nonenteric-coated aspirin. Annals of Pharmacotherapy 2002, 36:163-166.
16. Dammann H.G., Burkhardt F., Wolf N. Enteric coating of aspirin significantly decreases gastroduodenal mucosal lesions. Alimentary Pharmacology and Therapeutics 1999, 13:1109-1114.
17. Blondon H., Barbier J.P., Mahé I., et al. Gastroduodenal tolerability of medium dose enteric-coated aspirin: a placebo controlled endoscopic study of a new enteric-coated formation versus regular formation in healthy volunteers. Fundamental and Clinical Pharmacology 2000, 14:155-157.
18. Fujimori S., Seo T., Gudis K., et al. Prevention of nonsteroidal anti-inflammatory drug-induced small-intestinal injury by prostaglandin: a pilot randomized controlled trial evaluated by capsule endoscopy. Gastrointestinal Endoscopy 2009, 69:1339-1346.
19. Gralnek I.M., Defranchis R., Seidman E., et al. Development of a capsule endoscopy scoring index for small bowel mucosal inflammatory change. Alimentary Pharmacology and Therapeutics 2008, 27:146-154.
20. Endo H., Hosono K., Higurashi T., et al. Quantitative of low-dose aspirin-associated small bowel injury using a capsule endoscopy scoring index. Digestive Endoscopy 2011, 23:56-61.
21. Somasundaram S., Rafi S., Hayllar J., et al. Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine. Gut 1997, 41:344-353.
22. Shiotani A., Haruma K., Nishi R., et al. Randomized, double-blind, pilot study of geranylgeranylacetone versus placebo in patients taking low-dose enteric-coated aspirin. Low-dose aspirin-induced small bowel damage. Scandinavian Journal of Gastroenterology 2010, 45:292-298.
23. Fujimori S., Gudis K., Takahashi Y., et al. Distribution of small intestinal mucosal injuries as a result of NSAID administration. European Journal of Clinical Investigation 2010, 40:504-510.
24. Hirata Y., Kataoka H., Shimura T., et al. Incidence of gastrointestinal bleeding in patients with cardiovascular disease: buffered aspirin versus enteric-coated aspirin. Scandinavian Journal of Gastroenterology 2011, 46:803-809.
25. Watanabe T., Sugimori S., Kameda N., et al. Small bowel injury by low-dose enteric-coated aspirin and treatment with misoprostol: a pilot study. Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association 2008, 6:1279-1282.
26. Endo H., Higurashi T., Hosono K., et al. Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study. Journal of Gastroenterology 2011, 46:894-905.
27. Cryer B., Feldman M. Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans. Gastroenterology 1999, 117:17-25.